Drug name - Xcopri
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7598279 | SK LIFE | Neurotherapeutic azole compounds |
Oct, 2027
(5 years from now) | |
| CN101228138A | SK LIFE | Neurotherapeutic Azole Compounds |
Apr, 2026
(3 years from now) | |
| CN101228138B | SK LIFE | Nerve Healing Pyrrole Compound |
Apr, 2026
(3 years from now) | |
| IN286726B | SK LIFE | Neurotherapeutic Azole Compounds |
Apr, 2026
(3 years from now) | |
| IN200708902P1 | SK LIFE | Neurother Apeutic Azole Compounds |
Apr, 2026
(3 years from now) | |
| EP1879873A1 | SK LIFE | Neurotherapeutic Azole Compounds |
Apr, 2026
(3 years from now) | |
| EP1879873A4 | SK LIFE | Neurotherapeutic Azole Compounds |
Apr, 2026
(3 years from now) | |
| EP1879873B1 | SK LIFE | Neurotherapeutic Azole Compounds |
Apr, 2026
(3 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 12.5MG | TABLET;ORAL | Prescription |
| 25MG | TABLET;ORAL | Prescription |
| 50MG | TABLET;ORAL | Prescription |
| 100MG | TABLET;ORAL | Prescription |
| 150MG | TABLET;ORAL | Prescription |
| 200MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.